The chromatography resin market was valued at USD 2.8 billion in 2025 and is estimated at USD 3.0 billion in 2026. It is projected to reach USD 4.8 billion by 2033, a CAGR of 7.0% over 2026-2033. Resins are the working medium that separates and purifies proteins, monoclonal antibodies and nucleic acids, so the market’s growth follows the global biologics pipeline.

What Is Driving the Chromatography Resin Market?

The main driver is the rising need for biopharmaceutical purification. Demand for biologics, monoclonal antibodies, vaccines and recombinant proteins keeps growing. Every one of these products must be purified to strict standards before release, and chromatography resins do that work in downstream processing.

Three forces reinforce each other. Investment in biopharmaceutical manufacturing is rising, and biosimilar development adds more production lines that need purification media. Developers are also trying to shorten production timelines, which pushes buyers toward high-capacity ion-exchange, affinity and mixed-mode resins. Finally, stringent regulatory requirements for product purity and safety make high-performance resins a compliance necessity rather than a discretionary purchase.

A useful way to read this chromatography resin market is that purification demand is tied to production volume. Resin is consumed in every batch, so each approved biologic keeps generating demand long after launch.

The figures in this article draw on Grand View Research’s market analysis. Continue your research with their Prism AI tool for more data and insights.

Applications of Chromatography Resin: Where Demand Concentrates

Pharmaceutical and biotechnology is the dominant end use, with 83.0% of the market in 2025, driven by monoclonal antibody, vaccine and biologics manufacturing. Food and beverage is much smaller but is forecast to grow faster, at a 7.6% CAGR from 2026 to 2033. Growth there comes from food testing, quality assurance and contamination analysis, backed by tighter food safety rules.

By technique, ion exchange led in 2025 with 43.7% of revenue. It is preferred for separating charged biomolecules because it offers high resolution, scalability and cost-effectiveness. Size exclusion chromatography is projected to grow at 5.1%, a slower pace than the overall market. Its strength is separating molecules by size without altering their structure, which suits sensitive biomolecules in research laboratories and quality control.

By product, natural resins held 50.8% of the market in 2025. Agarose- and cellulose-based media are valued for biocompatibility and efficient binding in large-scale separation. Synthetic resins are expected to grow faster, at 7.7% from 2026 to 2033, as buyers look for chemical stability and durability. Silica-based resins also fall in the synthetic category and are widely used for their mechanical strength.

Download a free sample report or claim your copy of this full market intelligence report

Unique Insight: What the Segment Numbers Imply

Two readings go beyond the headline figures:

• Concentration risk. With 83.0% of revenue from pharma and biotech, the market behaves like a proxy for biologics manufacturing investment. Slower approvals or capital spending would affect resin demand more than any change in food or research use.
• A gradual material shift. Natural resins lead today, but synthetic resins growing at 7.7% against a 7.0% market average suggest share will slowly move toward engineered media. Faster growth in food and beverage (7.6%) also shows the market is diversifying beyond drug manufacturing, though from a small base.

Looking for more in-depth data focusing on specific segments or regions? Get this report customized with inclusion of custom data sets to suit your exact business needs

Regional Demand in the Chromatography Resin Market

North America led in 2025 with a 33.0% revenue share, supported by established biopharmaceutical manufacturing infrastructure and heavy biologics R&D spending. The U.S. accounts for 92.9% of North America’s revenue. As a rough calculation, that is about 31% of the global chromatography resin market from a single country.

Asia Pacific is the fastest-growing region over the forecast period, helped by rising healthcare expenditure, growing biologics production, and a strong presence of contract manufacturing organizations. China accounted for 44.8% of the regional market in 2025. Europe is anchored by strict quality standards and a strong life sciences base, with Germany as a key country market. Latin America and the Middle East & Africa are expanding as healthcare infrastructure and local biopharmaceutical activity develop.

Key Industry Players in the Chromatography Resin Market

The companies profiled in the Grand View Research study are:

• Merck KGaA
• Bio-Rad Laboratories, Inc.
• Wipro GE Healthcare Pvt Ltd
• Purolite Corporation
• W. R. Grace & Co.
• Mitsubishi Chemical Holdings Corporation
• Danaher Corporation
• Tosoh Corporation
• Thermo Fisher Scientific Inc.
• Sartorius AG

Explore the full list of profiled companies operating in this market with recent strategic initiatives

The market is moderately consolidated. Danaher, Merck KGaA and Bio-Rad Laboratories shape the competitive landscape through R&D capability, advanced manufacturing and global distribution networks. Grand View Research classes most of the list as mature players. Wipro GE Healthcare and Grace are positioned as emerging players, competing through application-specific solutions and regional expansion, though with narrower portfolios and lower manufacturing scale.

Strategic deals are also reshaping the field. In October 2025, Merck KGaA announced the acquisition of JSR Life Sciences’ chromatography business. This brought JSR’s Amsphere Protein A resin technology into Merck’s portfolio and strengthened its antibody purification capabilities. Players in Asia Pacific, Latin America and the Middle East & Africa are also expanding with cost-effective manufacturing and modern production facilities.

Restraints to Watch

Growth is not frictionless. The high cost of resins, limited reuse cycles and the complexity of large-scale purification continue to shape competition. For buyers, resin lifetime and cost per batch are often as important as binding capacity. For suppliers, the opportunity lies in longer-lasting, higher-capacity media.

Outlook

The chromatography resin market is on track to add roughly USD 1.8 billion between 2026 and 2033. That growth rests on biologics demand, regulatory pressure for purity and continued investment in downstream efficiency. Pharma and biotech buyers, high-volume ion-exchange applications and Asia Pacific production hubs are where the most momentum is expected.

Check Out Our Dedicated Business Offerings –

• Grand View Signal: Track commodity price intelligence in real time. See the signal